Pangen Biotech Inc

222110

Company Profile

  • Business description

    Pangen Biotech Inc is a biotechnology company. The company is engaged in the production and sales of biosimilar EPO drugs, contract manufacturing (CMO), and development technology transfer service (CDO) business for biopharmaceuticals, including non-clinical and clinical samples, and biopharmaceutical development business.

  • Contact

    306 Sinwon-ro, Yeongtong-gu
    4th floor, Yeongtong Innoplex 2nd building, Woncheon-dong
    Gyeonggi-do
    Suwon-si
    KOR

    T: +82 317339165

    https://www.pangen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    75

Stocks News & Analysis

stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks

Bapcor is paying for the sins of its past

Shares plunged over 17% after reporting disappointing results.
stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,401.0027.300.29%
CAC 408,206.0731.870.39%
DAX 4024,258.80427.811.80%
Dow JONES (US)46,706.58515.971.12%
FTSE 1009,403.5749.000.52%
HKSE26,206.17347.341.34%
NASDAQ22,990.54310.571.37%
Nikkei 22549,835.43649.931.32%
NZX 50 Index13,334.0610.90-0.08%
S&P 5006,735.1371.121.07%
S&P/ASX 2009,103.0027.100.30%
SSE Composite Index3,879.9216.020.41%

Market Movers